The enigmatic role of mast cells in dominant tolerance

被引:21
作者
de Vries, Victor C. [1 ]
Pino-Lagos, Karina [1 ]
Elgueta, Raul [1 ]
Noelle, Randolph J. [1 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
关键词
dominant tolerance; mast cells; regulatory T cells; REGULATORY T-CELLS; FC-EPSILON-RI; IMMUNOLOGICAL SELF-TOLERANCE; IGE RECEPTOR EXPRESSION; IN-VITRO; IMMUNE-RESPONSES; CUTTING EDGE; GRANZYME-B; SUPPRESSION; ACTIVATION;
D O I
10.1097/MOT.0b013e32832ce87a
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Purpose of review The role of regulatory T cells (T-reg) in peripheral tolerance has been studied extensively in transplantation research. Recently, mast cells have been shown to play an indispensable role in allograft tolerance. The purpose of this review is to inform the reader on the current standings of the role of mast cells in dominant tolerance with an emphasis on the interaction of mast cells with T-reg. Recent findings Mast cells are required to sustain peripheral tolerance via T-reg. T-reg can stabilize mast cells degranulation by contact-dependent mechanisms through the interaction of OX40 and its ligand OX40L, and by production of soluble factors, such as interleukin-10 and transforming growth factor-beta. Conversely, the activation and subsequent degranulation of mast cells break peripheral tolerance. Summary Both mast cells and T-reg are needed to create a local immunosuppressive environment in the transplant. T-reg are not only necessary to suppress effector T-cell responses but also to stabilize mast cells. Mast cells in return could contribute to the immunosuppressive state by release of transforming growth factor-beta, interleukin-10 and specific proteases. However, the molecular basis for mast cells control of T-reg suppression in organ transplantation is still unresolved.
引用
收藏
页码:332 / 337
页数:6
相关论文
共 78 条
[1]
AUNE TM, 1994, J IMMUNOL, V153, P489
[2]
Mast Cells Tryptase in Patients After Renal Transplantation [J].
Barczyk, M. ;
Mysliwiec, M. ;
Kalinowski, M. ;
Rowinski, M. ;
Brzosko, S. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (10) :3437-3439
[3]
Stat5 expression is required for IgE-mediated mast cell function [J].
Barnstein, Brian O. ;
Li, Geqiang ;
Wang, Zhengqi ;
Kennedy, Sarah ;
Chalfant, Charles ;
Nakajima, Hiroshi ;
Bunting, Kevin D. ;
Ryan, John J. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :3421-3426
[4]
Addition of a mast cell stabilizing compound to organ preservation solutions degreases lung reperfusion injury [J].
Barr, ML ;
Carey, JN ;
Nishanian, GP ;
Roberts, RF ;
Sakamaki, Y ;
Darbinian, SH ;
Starnes, VA .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (03) :631-636
[5]
BARR ML, 1931, J THORAC CARDIOVASC, V115, P636
[6]
All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation [J].
Benson, Micah J. ;
Pino-Lagos, Karina ;
Rosemblatt, Mario ;
Noelle, Randolph J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1765-1774
[7]
Influence of mast cells on outcome after heterotopic cardiac transplantation in rats [J].
Boerma, Marjan ;
Fiser, William P. ;
Hoyt, Grant ;
Berry, Gerald J. ;
Joseph, Lija ;
Joseph, Jacob ;
Wang, Junru ;
Crew, Mark D. ;
Robbins, Robert C. ;
Hauer-Jensen, Martin .
TRANSPLANT INTERNATIONAL, 2007, 20 (03) :256-265
[8]
BASOPHILS AND MAST-CELLS IN RENAL-ALLOGRAFT REJECTION [J].
COLVIN, RB ;
DVORAK, HF .
LANCET, 1974, 1 (7850) :212-214
[9]
Fc receptor biology [J].
Daeron, M .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :203-234
[10]
Davies JD, 1996, J IMMUNOL, V156, P3602